Evidence map›Paper›PMID 29031712›Full record

ArticleMolecular metabolism2017

Mitochondrial uncoupling in the melanocortin system differentially regulates NPY and POMC neurons to promote weight-loss.

Natalie Jane Michael, Stephanie Elise Simonds, Marco van den Top, Michael Alexander Cowley, David Spanswick

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. The potential role of hypothalamic POMCExperimental & molecular medicine · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Natalie Jane MichaelMetabolic Disease and Obesity Program, Biomedicine Discovery Institute, Monash University, Australia(5). Electronic address: Natalie.michael@monash.edu.
Stephanie Elise SimondsMetabolic Disease and Obesity Program, Biomedicine Discovery Institute, Monash University, Australia(5). Electronic address: Stephanie.simonds@monash.edu.
Marco van den TopNeurosolutions, Coventry, P.O. 3517, UK. Electronic address: Mvandentop@neurosolutionsltd.com.
Michael Alexander CowleyMetabolic Disease and Obesity Program, Biomedicine Discovery Institute, Monash University, Australia(5). Electronic address: Michael.cowley@monash.edu.
David SpanswickNeuroscience Program, Biomedicine Discovery Institute, Monash University, Australia(5); Neurosolutions, Coventry, P.O. 3517, UK; Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. Electronic address: David.Spanswick@monash.edu.
Discovery Institute · USHydrosolutions (Switzerland) · CHUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe mitochondrial uncoupling agent 2,4-dinitrophenol (DNP), historically used as a treatment for obesity, is known to cross the blood-brain-barrier, but its effects on central neural circuits controlling body weight are largely unknown. As hypothalamic melanocortin neuropeptide Y/agouti-related protein (NPY/AgRP) and pro-opiomelanocortin (POMC) neurons represent key central regulators of food intake and energy expenditure we investigated the effects of DNP on these neurons, food intake and energy expenditure.

methodC57BL/6 and melanocortin-4 receptor (MC4R) knock-out mice were administered DNP intracerebroventricularly (ICV) and the metabolic changes were characterized. The specific role of NPY and POMC neurons and the ionic mechanisms mediating the effects of uncoupling were examined with in vitro electrophysiology performed on NPY hrGFP or POMC eGFP mice.

resultsHere we show DNP-induced differential effects on melanocortin neurons including inhibiting orexigenic NPY and activating anorexigenic POMC neurons through independent ionic mechanisms coupled to mitochondrial function, consistent with an anorexigenic central effect. Central administration of DNP induced weight-loss, increased BAT thermogenesis and browning of white adipose tissue, and decreased food intake, effects that were absent in MC4R knock-out mice and blocked by the MC4R antagonist, AgRP.

conclusionThese data show a novel central anti-obesity mechanism of action of DNP and highlight the potential for selective melanocortin mitochondrial uncoupling to target metabolic disorders.

Indexed as

2,4-DinitrophenolAdipose Tissue, BrownAnimalsBody WeightEatingEnergy MetabolismMaleMelanocortinsMiceMice, Inbred C57BLMice, KnockoutMitochondriaNeuronsNeuropeptide YObesityPro-Opiomelanocortin2,4-DinitrophenolMelanocortinsNeuropeptide YPro-OpiomelanocortinReceptor, Melanocortin, Type 4Receptors, MelanocortinUncoupling Protein 1ATP-sensitive potassium channelBAT thermogenesisMitochondrial uncouplingNPYPOMCWeight-loss

Identifiers

PMID29031712
PMCPMC5641603
OpenAlexW2727527593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.